Phosphorylation sites in the cerebral cavernous malformations complex.

  title={Phosphorylation sites in the cerebral cavernous malformations complex.},
  author={Jaehong Kim and Nicholas E. Sherman and J. Wesley Fox and Mark H Ginsberg},
  journal={Journal of cell science},
  volume={124 Pt 23},
Phosphorylation sites in the cerebral cavernous malformations complex Jaehong Kim1,3, Nicholas E. Sherman2, Jay W. Fox2 and Mark H. Ginsberg1,* 1Department of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0726, USA 2Department of Microbiology, University of Virginia, Charlottesville, VA 22908, USA 3Division of Translational Research, National Medical Center Research Institute, Seoul, South Korea, 100-799 *Author for correspondence ( 

From This Paper

Figures, tables, and topics from this paper.


Publications referenced by this paper.
Showing 1-10 of 33 references

Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis

F. Francalanci, M. Avolio, +7 authors F Balzac
View 5 Excerpts
Highly Influenced

Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Disease models & mechanisms • 2010
View 3 Excerpts
Highly Influenced

Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.

Proceedings of the National Academy of Sciences of the United States of America • 2011
View 1 Excerpt